HALO
Halozyme Therapeutics, Inc. · Healthcare
SVP and Chief Technical Officer Michael J. Labarre sold $495K of Halozyme Therapeutics, Inc.
Sold$495,483
$49.55Price
10,000Shares
−7%Stake
What HALO did after the filing
- The stock from Tue, Feb 28 close, $47.99
- −24.3%
- S&P 500, same days
- +3.4%
Measured over 30 trading days, to the Apr 12 close.
Traded Mon, Feb 27. Filed Tue, Feb 28, 11:59 AM ET, during the session. Returns use the Feb 28 close and the Apr 12 close. Not investment advice.